DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an ...
Pharmac has today announced their decision to fund six medicines for cancer, including a combination treatment, and one ...
An expert explained the importance of the FDA’s approval of Ensacove for patients with ALK-positive non-small cell lung ...
Nuvation Bio, listed via SPAC in 2021, and acquired AnHeart Therapeutics last year, gaining taletrectinib, a promising ROS1 inhibitor indicated for non-small cell lung cancer. The FDA has accepted ...
The National Institute for Health and Care Excellence (NICE) today announced final draft guidance on Pfizer's Xalkori (crizotinib) and has not recommended it for use in previously-treated ...